Journal profile · HEMATOLOGY

Turkish Journal of Hematology

ISSN 1300-7777 · eISSN 1308-5263 · Aves · TURKEY · Quarterly · Founded 1995

Turkish Journal of Hematology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.53; fully open access; no APC; review about 1 month (community reports); community-reported acceptance: about 75%; 97 articles in 2025; indexed in SCIE and Scopus.

Impact factor1.53Latest value listed by LetPub
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 1 monthCommunity average
APCNo APCFully open access
Acceptanceabout 75%Community average
Articles per year972025 · OpenAlex count

Scope

Aims, scope and focus

Turkish Journal of Hematology is published by Aves and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Acute Myeloid Leukemia Research, Lymphoma Diagnosis and Treatment and Chronic Lymphocytic Leukemia Research, together about 25.8% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)

The Turkish Journal of Hematology is published quarterly (March, June, September, and December) by the Turkish Society of Hematology. It is an independent, non-profit peer-reviewed international English-language periodical encompassing subjects relevant to hematology. The Editorial Board of The Turkish Journal of Hematology adheres to the principles of the World Association of Medical Editors (WAME), International Council of Medical Journal Editors (ICMJE), Committee on Publication Ethics (COPE), Consolidated Standards of Reporting Trials (CONSORT) and Strengthening the Reporting of Observational Studies in Epidemiology (STROBE). The aim of The Turkish Journal of Hematology is to publish original hematological research of the highest scientific quality and clinical relevance. Additionally, educational material, reviews on basic developments, editorial short notes, images in hematology, and letters from hematology specialists and clinicians covering their experience and comments on hematology and related medical fields as well as social subjects are published. As of December 2015, The Turkish Journal of Hematology does not accept case reports. Important new findings or data about interesting hematological cases may be submitted as a brief report.

Source: LetPub

Research area (LetPub): HEMATOLOGY

Editor-in-chief Reyhan KüçükkayaPublisher website

Editorial board by country: none in mainland China; most named Türkiye 11 (11 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Acute Myeloid Leukemia ResearchMedicine9%
  2. Lymphoma Diagnosis and TreatmentMedicine8.5%
  3. Chronic Lymphocytic Leukemia ResearchMedicine8.3%
  4. Hemoglobinopathies and Related DisordersMedicine6.1%
  5. Chronic Myeloid Leukemia TreatmentsMedicine6.1%
  6. Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.3%
  7. Multiple Myeloma Research and TreatmentsMedicine5.3%
  8. Blood groups and transfusionMedicine5.1%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorHematologyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorHematologyZone 4

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorHematologyZone 4

Top journal: noReview journal: no

Database indexing

SCIEScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor
1.53LetPub ·
CiteScore 2026-06
2.7LetPub ·
SJR 2026-06
0.51LetPub ·
SNIP 2026-06
0.7LetPub ·
h-index
14LetPub ·
h-index
31OpenAlex ·
i10-index
227OpenAlex ·
2-year mean citedness
0.79OpenAlex ·
Self-citation rate
6.2%LetPub ·
Share of gold OA articles
98.84%LetPub ·

Volume

Articles per year
27LetPub ·

Articles by year OpenAlex count · 1,507 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026656543
2025979732
20246262102
20237777135
20225151144
20217676308

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 1 monthLetPub ·
Average acceptance (community reports)
75%LetPub ·
Peer review
Double anonymous peer reviewLetPub

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessOpenAlex

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Article types accepted6
  1. brief reportsBRIEF REPORTS 9. Increased Mast Cell Numbers in Bone Marrow of Patients with Myeloproliferative Neoplasms and PruritusLength not stated
  2. editorialEDITORIAL 1. 75 Years of Adventure in Turkish Scientific Medical Publishing: From Istanbul Contribution to Clinical Science to Turkish Journal of Hematology (19…Length not stated
  3. images in hematologyIMAGES IN HEMATOLOGY 11. Hemolytic Anemia in a Newborn: Thinking About Infantile PyknocytosisLength not stated
  4. letter to the editorLETTER TO THE EDITOR 13. CMV PCR Monitoring for Hematological MalignancyLength not stated
  5. original articleORIGINAL ARTICLE 2. Liver and Spleen Point Shear-Wave Elastography in Newly Diagnosed BCR: : ABL1-Negative Myeloproliferative NeoplasmsLength not stated
  6. perspective in hematologyPERSPECTIVE IN HEMATOLOGY 7. Antifungal Management in Patients with Hematological Malignancies: From Primary Prophylaxis to Empirical and Diagnosis-Driven Treat…Length not stated
Publisher website
Policy excerpts from the journal's websiteLicense & copyright
License & copyright

Copyright notice present Model summary

Copyright © 2026 Turkish Journal of Hematology

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Aves
Country or region
TURKEY
Language
English, Turkish
Frequency
Quarterly
Founded
1995
ISSN
1300-7777
Electronic ISSN
1308-5263
Official links

FAQ

Frequently asked questions about Turkish Journal of Hematology

What CAS zone is Turkish Journal of Hematology in?

In the 2025 upgraded edition of the CAS Journal Ranking, Turkish Journal of Hematology is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

What is the impact factor of Turkish Journal of Hematology?

The latest impact factor listed by LetPub is 1.53; CiteScore 2.7, h-index 31.

How long does peer review take at Turkish Journal of Hematology?

Authors report an average review time of about 1 month; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Turkish Journal of Hematology based?

Of the 11 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Türkiye (11). Counted from the institutions listed on the board page; for reference only.

Which databases index Turkish Journal of Hematology?

According to LetPub and DOAJ records, Turkish Journal of Hematology is indexed in SCIE, Scopus and DOAJ.

Is Turkish Journal of Hematology open access, and what is the APC?

Turkish Journal of Hematology is a fully open-access journal. It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .